Clinical Trials Logo

Clinical Trial Summary

The main risk of aortic aneurysms is rupture that leads to a high risk of death. A preventive surgical treatment is thus needed. In order to reduce the morbidity and mortality associated with conventional surgery, an endovascular approach (insertion of an endovascular stent graft)is now widely favored. The main problem of this procedure is the occurrence of endoleaks (persistence of a communication between the aneurysm and the aorta). A new approach is proposed to prevent these endoleaks. The principle is to draw blood from the patient, separate the blood from the platelets, and reinject both platelet rich plasma (PRP) and autologous thrombin, in order to form a platelet gel (PRP + autologous thrombin). Before studying the efficacy of this technique, its safety of use and feasibility must be evaluated.


Clinical Trial Description

The main risk of aortic aneurysms is rupture. Onset is usually sudden, leading to the death of the patient in 80% to 90% of cases. The elective treatment of abdominal aortic aneurysms, therefore, seems to be a priority. In order to reduce the morbidity and mortality associated with conventional surgery, an endovascular approach (insertion of an endovascular stent graft using the endovascular aneurysm repair procedure) is now widely favored. The main problem, during follow-up of patients wearing an endovascular stent graft, is the occurrence of endoleaks resulting in retrograde filling of the aneurysm sac. The ideal is to prevent these endoleaks either by new developments in endovascular stent grafts or by using adjuvant therapy during the procedure. The principle is to draw blood from the patient, separate the blood from the platelets, and reinject it into two separate catheters, one with platelet rich plasma (PRP) and the other with autologous thrombin, in order to form a platelet gel (PRP + autologous thrombin). Before studying the efficacy of this technique, its safety of use and feasibility must be evaluated. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00372138
Study type Interventional
Source Rennes University Hospital
Contact
Status Terminated
Phase N/A
Start date September 2006
Completion date July 2008

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02888613 - Mini-laparotomy Versus Mini Lumbotomy N/A
Recruiting NCT00662480 - Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark Phase 4
Completed NCT00989729 - Preoperative Methylprednisolone in Endovascular Aortic Repair N/A
Active, not recruiting NCT02345005 - Iliac Branch Excluder ReGistry (IceBERG)
Completed NCT01390740 - Observatory of Screening Aneurysms of the Abdominal Aorta During Echocardiography. National Epidemiological Survey
Completed NCT00833924 - Zenith(R) Low Profile AAA Endovascular Graft Clinical Study N/A
Terminated NCT00610090 - Safety Study for the Treatment of Abdominal Aortic Aneurysms Phase 2
Completed NCT02477111 - European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms
Recruiting NCT01538056 - Physician Modified Endovascular Grafts N/A
Completed NCT01106391 - A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION) N/A
Terminated NCT00444821 - The (PIVOTAL) Study N/A
Completed NCT01599533 - Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm N/A
Completed NCT01328197 - Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms Phase 1
Completed NCT00705718 - Endurant Bifurcated and Aorto-Uni-Iliac (AUI) Stent Graft System N/A
Completed NCT02125890 - Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms Phase 3
Completed NCT00875563 - Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study N/A
Completed NCT02048514 - The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms N/A
Terminated NCT00546013 - Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome N/A
Recruiting NCT05004051 - ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
Withdrawn NCT03965364 - China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)